H.C. Wainwright reiterates ‘Buy’ for Co-Diagnostics (NASDAQ:CODX) with a $35 Price Target as COVID-19 Surge Boosts Testing Demand

• NASDAQ: $CODX
• Notified: $18.00
• 07:30 EDT